Global Blood Therapeutics announces proposed public offering of common stock
Global Blood announced an agreement to sell $75.00 million in shares of its common stock in a registered underwritten public offering. In addition, GBT has granted the underwriter a 30-day option to purchase up to $11.25 million in shares of its common stock. February 21, 2017